Covered recipient · General Payments record
SAMUEL CHOULET
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2019–2021
$2,295.09
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $603.91 | 6 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $237.74 | 2 |
| Relypsa, Inc. | $116.00 | 1 |
| ABBVIE INC. | $102.44 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $97.91 | 1 |
| SK Life Science, Inc. | $49.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (6)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $102.44 | 11/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794255963 | CMS |
| Janssen Pharmaceuticals, Inc | $123.06 | 08/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 787655083 | CMS |
| Janssen Pharmaceuticals, Inc | $114.68 | 11/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 787655093 | CMS |
| SK Life Science, Inc. | $49.82 | 03/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826825945 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $97.91 | 10/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819891877 | CMS |
| Vifor Pharma, Inc. | $116.00 | 05/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 816105925 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.